(Q43503283)

English

N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1.

scientific article published in March 2000

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

1

object named as

F M Uckun

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

C Mao

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

S Pendergrass

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

D Maher

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

D Zhu

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

L Tuel-Ahlgren

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

T K Venkatachalam

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

135-140

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Solvent-accessible surfaces of proteins and nucleic acids

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100205

21 January 2018

Identifiers

10.1177/095632020001100205

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43503283&oldid=1614342466"